• Home
• About Us
  • Company Profile
  • Mission
  • Management
  • Scientific Advisors
  • Investors
• News
• Partners
• Research
• Products
  • AquADEKs
  • Aqua-E
  • 400/400
  • Omega-T
  • Antioxidant Factor
  • Tocotrienols
  • Maxi-Gamma
  • 100/100
  • Callisto Oil
  • Callisto Creme
• Quick Order
• FAQs
  • Ask the Doc
  • Product FAQs
  • Ordering FAQs
  • Shipping FAQs
  • Security & Privacy
  • Accounts FAQs
  • How to Choose Which Product
  • Where to Buy
  • Yasoo Health E-Club
• Shopping Cart
• International
• Contact Us

News

Yasoo Health Inc. Closes Series A Financing

July 1, 2002 - Yasoo Health Inc. (Yasoo) closed Series A financing from the Bank of Cyprus Ventures and Emergo. Yasoo plans to use this funding to upgrade its infrastructure, create awareness for its products, and develop new non-proprietary products and continue research for a new line of proprietary products that will help patients to manage chronic diseases. Yasoo's first product will target malabsorption of fat soluble vitamins in conditions such as cystic fibrosis and inflammatory bowel disease.